^
    BIOMARKER:

    DNMT3A mutation

    i
    Other names: DNMT3A, DNA Methyltransferase 3 Alpha, DNA (Cytosine-5-)-Methyltransferase 3 Alpha, DNA (Cytosine-5)-Methyltransferase 3A, DNA MTase HsaIIIA, DNA Cytosine Methyltransferase 3A2, DNA Methyltransferase HsaIIIA, DNMT3A2, Dnmt3a




    Show legend

    Include preclinical:
    Acute Myelogenous Leukemia
    Myelodysplastic Syndrome
    Non Small Cell Lung Cancer
    Lymphoma
    Triple Negative Breast Cancer
    Acute Lymphocytic Leukemia
    Chronic Myeloid Leukemia
    Colorectal Cancer
    T Cell Non-Hodgkin Lymphoma
    Peripheral T-cell Lymphoma
    HAG + azacitidine
    RVU120
    azacitidine
    PD-L1 inhibitor
    anlotinib + APL-502
    venetoclax
    decitabine/cedazuridine
    pembrolizumab
    azacitidine + romidepsin
    DCAG
    CHOP
    ARO-002
    quizartinib
    PC-002
    venetoclax + midostaurin
    cytarabine
    venetoclax + gilteritinib
    venetoclax + sorafenib
    decitabine
    sintilimab + fruquintinib
    lenalidomide
    gemtuzumab ozogamicin
    CHOP + azacitidine oral
    EPZ-5676
    ABBV-744